Literature DB >> 24641234

Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies.

Jean Bousquet, Christian Jorgensen, Michel Dauzat, Alfredo Cesario, Thierry Camuzat, Rodolphe Bourret, Nicolas Best, Josep M Anto, Frederic Abecassis, Pierre Aubas, Antoine Avignon, Melanie Badin, Anna Bedbrook, Hubert Blain, Arnaud Bourdin, Jacques Bringer, William Camu, Guilhaume Cayla, David J Costa, Philippe Courtet, Jean-Paul Cristol, Pascal Demoly, Jean-Emmanuel de la Coussaye, Pierre Fesler, Fares Gouzi, Jean-Christophe Gris, Bernard Guillot, Maurice Hayot, Claude Jeandel, Olivier Jonquet, Laurent Journot, Sylvain Lehmann, Gwenaelle Mathieu, Jacques Morel, Gregory Ninot, Jacques Pelissier, Marie-Christine Picot, Francoise Radier-Pontal, Jean-Marie Robine, Michel Rodier, Francois Roubille, Ariane Sultan, Anne Wojtusciszyn, Charles Auffray, Rudi Balling, Cristina Barbara, Anne Cambon-Thomsen, Niels H Chavannes, Alexander Chuchalin, George Crooks, Antoni Dedeu, Leonardo M Fabbri, Judith Garcia-Aymerich, Jawad Hajjam, Elisabete Melo Gomes, Susana Palkonen, Francois Piette, Christophe Pison, David Price, Boleslaw Samolinski, Holger J Schunemann, Peter J Sterk, Panayiotis Yiallouros, Josep Roca, Philippe Van de Perre, Jacques Mercier1.   

Abstract

Chronic diseases are diseases of long duration and slow progression. Major NCDs (cardiovascular diseases, cancer, chronic respiratory diseases, diabetes, rheumatologic diseases and mental health) represent the predominant health problem of the Century. The prevention and control of NCDs are the priority of the World Health Organization 2008 Action Plan, the United Nations 2010 Resolution and the European Union 2010 Council. The novel trend for the management of NCDs is evolving towards integrative, holistic approaches. NCDs are intertwined with ageing. The European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) has prioritised NCDs. To tackle them in their totality in order to reduce their burden and societal impact, it is proposed that NCDs should be considered as a single expression of disease with different risk factors and entities. An innovative integrated health system built around systems medicine and strategic partnerships is proposed to combat NCDs. It includes (i) understanding the social, economic, environmental, genetic determinants, as well as the molecular and cellular mechanisms underlying NCDs; (ii) primary care and practice-based interprofessional collaboration; (iii) carefully phenotyped patients; (iv) development of unbiased and accurate biomarkers for comorbidities, severity and follow up of patients; (v) socio-economic science; (vi) development of guidelines; (vii) training; and (viii) policy decisions. The results could be applicable to all countries and adapted to local needs, economy and health systems. This paper reviews the complexity of NCDs intertwined with ageing. It gives an overview of the problem and proposes two practical examples of systems medicine (MeDALL) applied to allergy and to NCD co-morbidities (MACVIA-LR, Reference Site of the European Innovation Partnership on Active and Healthy Ageing).

Entities:  

Mesh:

Year:  2014        PMID: 24641234     DOI: 10.2174/1381612820666140314115505

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  17 in total

1.  DG Connect Funded Projects on Information and Communication Technologies (ICT) for Old Age People: Beyond Silos, CareWell and SmartCare.

Authors:  W Keijser; E de Manuel-Keenoy; M d'Angelantonio; P Stafylas; P Hobson; G Apuzzo; M Hurtado; J Oates; J Bousquet; A Senn
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

Review 2.  Late-Onset ADHD: Understanding the Evidence and Building Theoretical Frameworks.

Authors:  Arthur Caye; Margaret H Sibley; James M Swanson; Luis Augusto Rohde
Journal:  Curr Psychiatry Rep       Date:  2017-11-13       Impact factor: 5.285

3.  Integrated chronic disease management to avoid emergency departments: the MACVIA-LR® approach.

Authors:  Pierre-Géraud Claret; Xavier Bobbia; Olivier Jonquet; Jean Bousquet; Jean-Emmanuel de La Coussaye
Journal:  Intern Emerg Med       Date:  2014-08-28       Impact factor: 3.397

Review 4.  Systems medicine: evolution of systems biology from bench to bedside.

Authors:  Rui-Sheng Wang; Bradley A Maron; Joseph Loscalzo
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2015-04-17

Review 5.  Improving the predictive value of interventional animal models data.

Authors:  Caroline J Zeiss
Journal:  Drug Discov Today       Date:  2014-11-04       Impact factor: 7.851

6.  Operational Definition of Active and Healthy Ageing (AHA): A Conceptual Framework.

Authors:  J Bousquet; D Kuh; M Bewick; T Standberg; J Farrell; R Pengelly; M E Joel; L Rodriguez Mañas; J Mercier; J Bringer; T Camuzat; R Bourret; A Bedbrook; M L Kowalski; B Samolinski; S Bonini; C Brayne; J P Michel; J Venne; P Viriot-Durandal; J Alonso; A Avignon; Y Ben-Shlomo; P J Bousquet; B Combe; R Cooper; R Hardy; G Iaccarino; T Keil; E Kesse-Guyot; I Momas; K Ritchie; J M Robine; C Thijs; C Tischer; B Vellas; A Zaidi; F Alonso; K Andersen Ranberg; V Andreeva; J Ankri; S Arnavielhe; H Arshad; P Augé; C Berr; P Bertone; H Blain; A Blasimme; G J Buijs; D Caimmi; A Carriazo; A Cesario; J Coletta; T Cosco; M Criton; F Cuisinier; P Demoly; S Fernandez-Nocelo; B Fougère; J Garcia-Aymerich; M Goldberg; N Guldemond; Z Gutter; D Harman; A Hendry; D Heve; M Illario; C Jeandel; S Krauss-Etschmann; O Krys; D Kula; D Laune; S Lehmann; D Maier; J Malva; P Matignon; E Melen; G Mercier; G Moda; A Nizinkska; M Nogues; M O'Neill; J Y Pelissier; D Poethig; D Porta; D Postma; F Puisieux; M Richards; C Robalo-Cordeiro; V Romano; F Roubille; H Schulz; A Scott; P Senesse; S Slagter; H A Smit; D Somekh; M Stafford; J Suanzes; A Todo-Bom; J Touchon; V Traver-Salcedo; M Van Beurden; R Varraso; I Vergara; E Villalba-Mora; N Wilson; E Wouters; M Zins
Journal:  J Nutr Health Aging       Date:  2015-11       Impact factor: 4.075

Review 7.  Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

Authors:  J Bousquet; J Farrell; G Crooks; P Hellings; E H Bel; M Bewick; N H Chavannes; J Correia de Sousa; A A Cruz; T Haahtela; G Joos; N Khaltaev; J Malva; A Muraro; M Nogues; S Palkonen; S Pedersen; C Robalo-Cordeiro; B Samolinski; T Strandberg; A Valiulis; A Yorgancioglu; T Zuberbier; A Bedbrook; W Aberer; M Adachi; A Agusti; C A Akdis; M Akdis; J Ankri; A Alonso; I Annesi-Maesano; I J Ansotegui; J M Anto; S Arnavielhe; H Arshad; C Bai; I Baiardini; C Bachert; A K Baigenzhin; C Barbara; E D Bateman; B Beghé; A Ben Kheder; K S Bennoor; M Benson; K C Bergmann; T Bieber; C Bindslev-Jensen; L Bjermer; H Blain; F Blasi; A L Boner; M Bonini; S Bonini; S Bosnic-Anticevitch; L P Boulet; R Bourret; P J Bousquet; F Braido; A H Briggs; C E Brightling; J Brozek; R Buhl; P G Burney; A Bush; F Caballero-Fonseca; D Caimmi; M A Calderon; P M Calverley; P A M Camargos; G W Canonica; T Camuzat; K H Carlsen; W Carr; A Carriazo; T Casale; A M Cepeda Sarabia; L Chatzi; Y Z Chen; R Chiron; E Chkhartishvili; A G Chuchalin; K F Chung; G Ciprandi; I Cirule; L Cox; D J Costa; A Custovic; R Dahl; S E Dahlen; U Darsow; G De Carlo; F De Blay; T Dedeu; D Deleanu; E De Manuel Keenoy; P Demoly; J A Denburg; P Devillier; A Didier; A T Dinh-Xuan; R Djukanovic; D Dokic; H Douagui; G Dray; R Dubakiene; S R Durham; M S Dykewicz; Y El-Gamal; R Emuzyte; L M Fabbri; M Fletcher; A Fiocchi; A Fink Wagner; J Fonseca; W J Fokkens; F Forastiere; P Frith; M Gaga; A Gamkrelidze; J Garces; J Garcia-Aymerich; B Gemicioğlu; J E Gereda; S González Diaz; M Gotua; I Grisle; L Grouse; Z Gutter; M A Guzmán; L G Heaney; B Hellquist-Dahl; D Henderson; A Hendry; J Heinrich; D Heve; F Horak; J O' B Hourihane; P Howarth; M Humbert; M E Hyland; M Illario; J C Ivancevich; J R Jardim; E J Jares; C Jeandel; C Jenkins; S L Johnston; O Jonquet; K Julge; K S Jung; J Just; I Kaidashev; M R Kaitov; O Kalayci; A F Kalyoncu; T Keil; P K Keith; L Klimek; B Koffi N'Goran; V Kolek; G H Koppelman; M L Kowalski; I Kull; P Kuna; V Kvedariene; B Lambrecht; S Lau; D Larenas-Linnemann; D Laune; L T T Le; P Lieberman; B Lipworth; J Li; K Lodrup Carlsen; R Louis; W MacNee; Y Magard; A Magnan; B Mahboub; A Mair; I Majer; M J Makela; P Manning; S Mara; G D Marshall; M R Masjedi; P Matignon; M Maurer; S Mavale-Manuel; E Melén; E Melo-Gomes; E O Meltzer; A Menzies-Gow; H Merk; J P Michel; N Miculinic; F Mihaltan; B Milenkovic; G M Y Mohammad; M Molimard; I Momas; A Montilla-Santana; M Morais-Almeida; M Morgan; R Mösges; J Mullol; S Nafti; L Namazova-Baranova; R Naclerio; A Neou; H Neffen; K Nekam; B Niggemann; G Ninot; T D Nyembue; R E O'Hehir; K Ohta; Y Okamoto; K Okubo; S Ouedraogo; P Paggiaro; I Pali-Schöll; P Panzner; N Papadopoulos; A Papi; H S Park; G Passalacqua; I Pavord; R Pawankar; R Pengelly; O Pfaar; R Picard; B Pigearias; I Pin; D Plavec; D Poethig; W Pohl; T A Popov; F Portejoie; P Potter; D Postma; D Price; K F Rabe; F Raciborski; F Radier Pontal; S Repka-Ramirez; S Reitamo; S Rennard; F Rodenas; J Roberts; J Roca; L Rodriguez Mañas; C Rolland; M Roman Rodriguez; A Romano; J Rosado-Pinto; N Rosario; L Rosenwasser; M Rottem; D Ryan; M Sanchez-Borges; G K Scadding; H J Schunemann; E Serrano; P Schmid-Grendelmeier; H Schulz; A Sheikh; M Shields; N Siafakas; Y Sibille; T Similowski; F E R Simons; J C Sisul; I Skrindo; H A Smit; D Solé; T Sooronbaev; O Spranger; R Stelmach; P J Sterk; J Sunyer; C Thijs; T To; A Todo-Bom; M Triggiani; R Valenta; A L Valero; E Valia; E Valovirta; E Van Ganse; M van Hage; O Vandenplas; T Vasankari; B Vellas; J Vestbo; G Vezzani; P Vichyanond; G Viegi; C Vogelmeier; T Vontetsianos; M Wagenmann; B Wallaert; S Walker; D Y Wang; U Wahn; M Wickman; D M Williams; S Williams; J Wright; B P Yawn; P K Yiallouros; O M Yusuf; A Zaidi; H J Zar; M E Zernotti; L Zhang; N Zhong; M Zidarn; J Mercier
Journal:  Clin Transl Allergy       Date:  2016-07-29       Impact factor: 5.871

Review 8.  Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project.

Authors:  M A Calderon; P Demoly; T Casale; C A Akdis; C Bachert; M Bewick; B M Bilò; B Bohle; S Bonini; A Bush; D P Caimmi; G W Canonica; V Cardona; A M Chiriac; L Cox; A Custovic; F De Blay; P Devillier; A Didier; G Di Lorenzo; G Du Toit; S R Durham; P Eng; A Fiocchi; A T Fox; R Gerth van Wijk; R M Gomez; T Haathela; S Halken; P W Hellings; L Jacobsen; J Just; L K Tanno; J Kleine-Tebbe; L Klimek; E F Knol; P Kuna; D E Larenas-Linnemann; A Linneberg; M Matricardi; H J Malling; R Moesges; J Mullol; A Muraro; N Papadopoulos; G Passalacqua; E Pastorello; O Pfaar; D Price; P Rodriguez Del Rio; R Ruëff; B Samolinski; G K Scadding; G Senti; M H Shamji; A Sheikh; J C Sisul; D Sole; G J Sturm; A Tabar; R Van Ree; M T Ventura; C Vidal; E M Varga; M Worm; T Zuberbier; J Bousquet
Journal:  Clin Transl Allergy       Date:  2016-11-23       Impact factor: 5.871

9.  The new holism: P4 systems medicine and the medicalization of health and life itself.

Authors:  Henrik Vogt; Bjørn Hofmann; Linn Getz
Journal:  Med Health Care Philos       Date:  2016-06

Review 10.  Allergen Immunotherapy (AIT): a prototype of Precision Medicine.

Authors:  G W Canonica; C Bachert; P Hellings; D Ryan; E Valovirta; M Wickman; O De Beaumont; J Bousquet
Journal:  World Allergy Organ J       Date:  2015-11-10       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.